BioMarin Pharmaceutical Inc. buy Citigroup Inc.
Start price
16.07.26
/
50%
€51.44
Target price
16.07.27
€66.28
Performance (%)
1.59%
Price
27.07.26
€53.00
Summary
This prediction is currently active. With a performance of 1.59%, the BUY prediction by Citigroup_Inc_ for BioMarin Pharmaceutical Inc. is trending in the right direction. This prediction currently runs until 16.07.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| BioMarin Pharmaceutical Inc. | 2.356% |
| iShares Core DAX® | 2.992% |
| iShares Nasdaq 100 | -1.584% |
| iShares Nikkei 225® | -2.254% |
| iShares S&P 500 | -0.009% |
Comments by Citigroup_Inc_ for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical (BMRN) had its price target raised by Citigroup Inc. from $75.00 to $76.00. They now have a "buy" rating on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€42.91
19.05.26
19.05.26
€64.43
19.05.27
19.05.27
23.51%
27.07.26
27.07.26
